Opportunity Information: Apply for PAR 08 258
Apply for PAR 08 258
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Center for Inherited Disease Research (CIDR) High Throughput Genotyping Resource Access (X01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172 Human Genome Research.
- This funding opportunity was created on Aug 28, 2008 and posted on Aug 28, 2008.
- Applicants must submit their applications by Jul 1, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: County governments Native American tribal governments (Federally recognized) Small businesses City or township governments Special district governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Center for Inherited Disease Research (CIDR) High Throughput Genotyping Resource Access (X01) opportunity (Funding Opportunity Number PAR 08-258) is an NIH program that gives researchers access to CIDR's large-scale genotyping and related statistical genetics support, with the goal of helping studies identify genetic factors that influence human health and disease. CIDR is set up as a centralized, high-throughput resource that can process large numbers of samples using current genotyping technologies, making it especially useful for projects that need genome-wide data or other high-volume genotyping to test genetic associations. While CIDR primarily focuses on multifactorial hereditary diseases (conditions influenced by multiple genes and often environmental factors), the program notes that other types of genetics projects may also be considered if they fit the resource's capabilities.
A key feature of this opportunity is that it uses the X01 mechanism, which is a resource access award rather than a typical grant that provides money to the applicant. In practical terms, recipients do not receive direct funding and there are no dollars awarded to the applicant organization through the X01. Instead, the value comes from access to CIDR's genotyping capacity, which is supported by NIH through its funding of CIDR. Because of that structure, applicants are expected to secure prior approval from an NIH Institute or Center that will support the project, or clearly explain how the genotyping costs and related support will be covered. Approved applications are coded as X01s to reflect that the award is for access to the NIH-supported genotyping resource rather than an applicant-held budget.
This is described as an NIH-wide initiative managed by the National Human Genome Research Institute (NHGRI), meaning it is intended to serve a broad range of NIH-relevant disease and trait research areas rather than being limited to a single institute's mission. Details on CIDR's current platforms, capabilities, and service offerings are maintained by CIDR and referenced through its website (http://www.cidr.jhmi.edu), which applicants are expected to consult to understand what types of assays and study designs can be supported.
Eligibility is broad and includes many common applicant types that participate in U.S. federal research programs. Eligible applicants include public and private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (including small businesses and other for-profits), and multiple levels of government (state, county, city/township, special districts), as well as public housing authorities/Indian housing authorities. The opportunity also explicitly includes a wide range of mission-focused and community-serving institutions and entities, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, tribally controlled colleges and universities (TCCUs), and tribal governments and tribal organizations (including those other than federally recognized tribal governments). It further allows U.S. territories or possessions, regional organizations, eligible federal agencies, faith-based or community-based organizations, and even non-U.S. (foreign) entities to apply, reflecting the NIH-wide, resource-oriented nature of the program.
Administratively, the opportunity is categorized under Health and is associated with CFDA number 93.172 (Human Genome Research). It was originally posted on August 28, 2008, with an original closing date of July 1, 2011 (and the same current closing date listed), and it was archived on August 1, 2011. The official announcement is available via the NIH Grants Guide link provided in the listing, and technical issues accessing the notice are directed to the NIH Office of Extramural Research (OER) Webmaster contact.
FAQs: CIDR High Throughput Genotyping Resource Access (X01) - PAR 08-258
What is the CIDR High Throughput Genotyping Resource Access (X01) opportunity?
It is an NIH program that provides researchers access to the Center for Inherited Disease Research (CIDR) for large-scale, high-throughput genotyping and related statistical genetics support. The goal is to help studies identify genetic factors that influence human health and disease.
What is the Funding Opportunity Number for this program?
The Funding Opportunity Number is PAR 08-258.
What does CIDR provide through this opportunity?
CIDR provides centralized, high-throughput genotyping services capable of processing large numbers of samples using current genotyping technologies, along with related statistical genetics support.
What types of projects is this opportunity intended to support?
The program is especially useful for projects that need genome-wide data or other high-volume genotyping to test genetic associations. CIDR primarily focuses on multifactorial hereditary diseases (conditions influenced by multiple genes and often environmental factors), but other genetics projects may also be considered if they fit CIDR's capabilities.
What is the X01 mechanism, and how is it different from a typical grant?
The X01 is a resource access award, not a standard grant that provides money to the applicant. Recipients do not receive direct funding, and there are no dollars awarded to the applicant organization through the X01. The value of the award is access to NIH-supported CIDR genotyping capacity and related support.
Will my organization receive money if we are approved?
No. Under the X01 mechanism, there are no funds awarded directly to the applicant organization. The award reflects access to the CIDR resource supported by NIH.
How are genotyping costs and related support covered if no funds are awarded to applicants?
Because this is resource access rather than direct funding, applicants are expected to secure prior approval from an NIH Institute or Center that will support the project, or clearly explain how the genotyping costs and related support will be covered.
Does this opportunity require prior approval from an NIH Institute or Center?
The program indicates applicants are expected to secure prior approval from an NIH Institute or Center that will support the project, or clearly explain the plan for covering genotyping costs and related support.
Who manages this opportunity within NIH?
It is an NIH-wide initiative managed by the National Human Genome Research Institute (NHGRI).
Is this opportunity limited to one NIH Institute's mission area?
No. It is described as an NIH-wide initiative intended to serve a broad range of NIH-relevant disease and trait research areas.
Where can applicants find CIDR's current genotyping platforms and capabilities?
Details on CIDR's current platforms, capabilities, and service offerings are maintained by CIDR and referenced through its website at http://www.cidr.jhmi.edu. Applicants are expected to consult that site to understand what assays and study designs can be supported.
Why is CIDR described as a centralized, high-throughput resource?
CIDR is set up to process large numbers of samples using current genotyping technologies, which makes it well-suited for high-volume genotyping needs such as genome-wide studies and other association-focused analyses.
What kinds of applicants are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofits (501(c)(3) and non-501(c)(3)); for-profit organizations (including small businesses and other for-profits); and multiple levels of government (state, county, city/township, special districts), as well as public housing authorities/Indian housing authorities.
Are minority-serving institutions explicitly eligible?
Yes. The opportunity explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and tribally controlled colleges and universities (TCCUs).
Are tribal governments and tribal organizations eligible?
Yes. It includes tribal governments and tribal organizations, including those other than federally recognized tribal governments.
Can organizations in U.S. territories or possessions apply?
Yes. U.S. territories or possessions are listed as eligible applicants.
Are regional organizations eligible?
Yes. Regional organizations are included among eligible applicants.
Are eligible federal agencies allowed to apply?
Yes. Eligible federal agencies are included in the eligibility list.
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are included as eligible applicants.
Can non-U.S. (foreign) entities apply?
Yes. The opportunity indicates that non-U.S. (foreign) entities are eligible to apply.
What is the program area or category for this opportunity?
The opportunity is categorized under Health.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA number 93.172 (Human Genome Research).
When was this opportunity posted and when did it close?
It was originally posted on August 28, 2008. The original closing date is listed as July 1, 2011 (and the same date is shown as the current closing date in the listing).
Is this opportunity currently active?
No. The listing indicates it was archived on August 1, 2011.
Where can I find the official announcement text?
The official announcement is available via the NIH Grants Guide link provided in the listing.
Who should be contacted for technical issues accessing the NIH notice?
Technical issues accessing the notice are directed to the NIH Office of Extramural Research (OER) Webmaster contact.
What does it mean that approved applications are "coded as X01s"?
It means the application is awarded under an X01 activity code to reflect that the award is for access to the NIH-supported genotyping resource, rather than an award that carries an applicant-held budget.
Does CIDR only support studies on inherited diseases?
CIDR primarily focuses on multifactorial hereditary diseases, but the program notes that other types of genetics projects may also be considered if they fit CIDR's resource capabilities.
Browse more opportunities from the same category: Health
Next opportunity: NIDA Research Center of Excellence Grant Program (P50)
Previous opportunity: NINR AREA for Health Disparities Research at Minority Serving Institutions (MSIs ) (R15)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 08 258
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 08 258) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing Centers for Intervention and/or Services Research (DCISR) (P20) Apply for PAR 08 087 Funding Number: PAR 08 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advanced Centers for Intervention and/or Services Research (ACISR) (P30) Apply for PAR 08 088 Funding Number: PAR 08 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Microbiome of the Lung and Respiratory Tract in HIV Infected Individuals and HIV Uninfected Controls (U01) Apply for RFA HL 09 006 Funding Number: RFA HL 09 006 Agency: National Institutes of Health Category: Health Funding Amount: $525,000 |
| NHLBI Cardiac Development Consortium (U01) Apply for RFA HL 09 002 Funding Number: RFA HL 09 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 1000 Genomes Project Dataset Analysis (U01) Apply for RFA HG 09 002 Funding Number: RFA HG 09 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NHLBI Pediatric Cardiac Genomics Consortium (U01) Apply for RFA HL 09 003 Funding Number: RFA HL 09 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Pediatric Translational Consortium Administrative Coordinating Center (U01) Apply for RFA HL 09 011 Funding Number: RFA HL 09 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cardiac Translational Research Implementation Program (C TRIP) (P20) Apply for RFA HL 10 001 Funding Number: RFA HL 10 001 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Patient Reported Outcomes Measurement Information System (PROMIS) Network Center (U54) Apply for RFA RM 08 022 Funding Number: RFA RM 08 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Reported Outcomes Measurement Information System (PROMIS) Research Sites (U01) Apply for RFA RM 08 023 Funding Number: RFA RM 08 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Reported Outcomes Measurement Information System (PROMIS) Technology Center (U54) Apply for RFA RM 08 024 Funding Number: RFA RM 08 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Reported Outcomes Measurement Information System (PROMIS) Statistical Center (U54) Apply for RFA RM 08 025 Funding Number: RFA RM 08 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Small Grant Program For New Investigators (R03) Apply for PAR 09 031 Funding Number: PAR 09 031 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Malaria Communities Program FY09 RFA Apply for M OAA GH 09 252 Funding Number: M OAA GH 09 252 Agency: Agency for International Development Category: Health Funding Amount: $1,500,000 |
| Influenza and Other Emerging Infectious Diseases in Vietnam (U01) Apply for RFA IP 09 002 Funding Number: RFA IP 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Research and Public Health Practice on Influenza and other respiratory infectious diseases in the Middle East, Southeast Asia, and South American regions Apply for RFA IP 09 004 Funding Number: RFA IP 09 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Academic Research Enhancement Award (R15) Apply for PA 06 042 Funding Number: PA 06 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Patient Oriented Research Grant (R21) Apply for PA 06 086 Funding Number: PA 06 086 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology (R03) Apply for PAR 06 211 Funding Number: PAR 06 211 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Retirement Economics (R03) Apply for PA 06 235 Funding Number: PA 06 235 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 08 258", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.